Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Universitäts Frauenklinik · Goethe University Frankfurt · +20 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,028
total citations
- FWCI
- 40.27
- Percentile
- 100%
- References
- 35
Citations per year
Authors
26- GVGϋnter von MinckwitzCorresponding
Universitäts Frauenklinik, Goethe University Frankfurt, German Breast group
- ASAndreas Schneeweiß
National Center for Tumor Diseases, Heidelberg University
- SLSibylle Loibl
Sana Klinikum Offenbach, German Breast group
- CSChristoph Salat
Praxis für Hämatologie und Onkologie
- CDCarsten Denkert
Charité - Universitätsmedizin Berlin
Topics & keywords
Topics
Keywords
- Carboplatin
- Medicine
- Breast cancer
- Lapatinib
- Triple-negative breast cancer
- Internal medicine
- Trastuzumab
- Taxane
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.